News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
GuruFocus.com6d agoneutral
Eli Lilly Stocks Move Lower With Higher Target Facing a Volume-Price TradeoffMotley Fool6d agoneutral
Here's Why I Think Every Investor Needs to Invest in These "Miracle" Drugs24/7 Wall St.6d agobullish
Eli Lilly Jumped 6% After Earnings. It’s Up 68% in a Year. Where Does the Target Go Now?GuruFocus.com6d agoneutral
What State Street Health Care SPDR (XLV) Bought: Eli Lilly Leads on Oct. 29MT Newswires6d agoneutral
Cantor Fitzgerald Adjusts Price Target on Eli Lilly to $1,600 From $1,440MT Newswires6d agoneutral
Berenberg Adjusts Price Target on Eli Lilly and Company to $1,570 From $1,400GlobeNewswire6d agoneutral
GENFIT to Highlight Progress in ACLF and MASH Diagnostics at AASLD The Liver Meeting® 2026Simply Wall St.6d agobullish
Eli Lilly (LLY) Unveils Diabetes Cancer And Colitis Trial Wins Across Its PipelineSimply Wall St.7d agoneutral
Eli Lilly (LLY) Stock Sees Modest Fair Value Lift As Analysts Rework GLP 1 OutlookMotley Fool8d agobullish
After Eli Lilly’s Explosive Earnings Report, Is It Too Late to Buy the Stock?Motley Fool8d agoneutral
Prediction: $100 per Month Invested in Eli Lilly (LLY) Stock Will Be Worth This Much by 2030